Federal Appellate Court Revives Tylenol Autism Claims
In its Opinion dated July 13, 2026, the United States Court of Appeals for the Second Circuit overturned dismissals of Plaintiffs’ failure-to-warn claims under state law relating to acetaminophen, the active ingredient in Tylenol and its generic equivalents. The Plaintiffs are children, parent[...]